Literature DB >> 10084319

In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients.

M Schaller1, B Hube, M W Ollert, W Schäfer, M Borg-von Zepelin, E Thoma-Greber, H C Korting.   

Abstract

Isoforms of aspartyl proteinase (Sap), which are encoded by at least nine related SAP genes, have been implicated to be a major virulence factor of the opportunistic yeast Candida albicans in experimental infections. Although it is generally assumed that proteinases are important for infections, detailed information on the pathogenetic role of Saps is still lacking. The same applies to the question whether the genes and corresponding isoforms of the enzyme are expressed during oral infection. For in vivo investigations, parts of the lesional oral epithelium were collected from three HIV-infected patients with oropharyngeal candidiasis. Immunoelectron microscopy was performed (pre- and post-embedding gold labeling with silver enhancement) using an anti-Sap murine monoclonal antibody directed against the gene products Sap1-3. It was possible to demonstrate expression of Sap antigens in each of the three samples of human oral candidiasis. This suggests that at least one of the genes SAP1-3 was expressed at the time of sample collection. Furthermore, a possible role of the enzymes during the interaction of yeast cells and mucosal cells is suggested: the majority of Sap antigens is secreted by those C. albicans cells that adhere directly to the epithelial surface. Sap immunoreactivity can be detected in particular at the site of close contact between C. albicans and epithelial cells, suggesting a pathogenetic role of the Saps in host-fungal interaction. Thus, inhibition of the enzyme might prove to be an important alternative in the prevention and treatment of candidiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084319     DOI: 10.1046/j.1523-1747.1999.00525.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  "In vitro" antifungal activity of protease inhibitors.

Authors:  S Mata-Essayag; S Magaldi; C Hartung de Capriles; L Deibis; G Verde; C Perez
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

2.  HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2010-02-26

Review 3.  A review of the ultrastructural features of superficial candidiasis.

Authors:  J A M S Jayatilake
Journal:  Mycopathologia       Date:  2010-10-22       Impact factor: 2.574

4.  Zinc Cluster Transcription Factors Alter Virulence in Candida albicans.

Authors:  Luca Issi; Rhys A Farrer; Kelly Pastor; Benjamin Landry; Toni Delorey; George W Bell; Dawn A Thompson; Christina A Cuomo; Reeta P Rao
Journal:  Genetics       Date:  2016-12-07       Impact factor: 4.562

5.  Tetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening.

Authors:  Peter Staib; Ulrich Lermann; Julia Blass-Warmuth; Björn Degel; Reinhard Würzner; Michel Monod; Tanja Schirmeister; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 6.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

7.  The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium.

Authors:  Martin Schaller; Matthias Bein; Hans C Korting; Stefan Baur; Gerald Hamm; Michel Monod; Sabine Beinhauer; Bernhard Hube
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Candida albicans releases soluble factors that potentiate cytokine production by human cells through a protease-activated receptor 1- and 2-independent pathway.

Authors:  Shih-Chin Cheng; Louis Y A Chai; Leo A B Joosten; Anna Vecchiarelli; Bernhard Hube; Jos W Van Der Meer; Bart Jan Kullberg; Mihai G Netea
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

9.  Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro.

Authors:  A Mayr; G Hinterberger; M P Dierich; C Lass-Flörl
Journal:  Int J Antimicrob Agents       Date:  2005-10       Impact factor: 5.283

Review 10.  Integrating Inflammasome Signaling in Sexually Transmitted Infections.

Authors:  Christopher Lupfer; Paras K Anand
Journal:  Trends Immunol       Date:  2016-08-31       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.